| Literature DB >> 35340480 |
Surekha Tayade1, Sparsh Madaan1, Sunil Kumar2, Dhruv Talwar2, Arzoo Chadha1.
Abstract
Tropical diseases such as malaria, dengue, intestinal helminths, schistosomiasis, leishmaniasis, and filariasis have an essential influence on the reproductive health of patients. Various cases of pregnancy loss in unexplained circumstances are a result of underdiagnosed tropical diseases. Term pregnancy complicated by tropical diseases is a challenge for the treating clinicians as these infections tend to mimic HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelets) syndrome and increase the chances of perinatal complications and maternal mortality. Except for tropical diseases, ever since the conception of the COVID-19 pandemic, the differentials for fever pregnancy have become extensive, and the treating clinicians need to solve the puzzle of the etiology behind these symptoms that are non-specific and might be due to both COVID-19 and tropical Infections. Prophylactic treatment for malaria is pivotal in pregnancy as immunity is decreased during pregnancy, making the patient susceptible to developing malaria-related complications. Dengue is one of the most common mosquito-borne infections found around the globe. Complications of dengue during pregnancy include pregnancy loss as well as vertical transmission of infection to the fetus. Leptospirosis, even though rare, has a wide range of complications in pregnancy ranging from fetal loss to congenital infection and oligohydramnios, thereby requiring close monitoring and prompt management during pregnancy. We report a case series of three cases where patients presented during the period of pregnancy with fulminant hepatic failure, which turned out to be a consequence of tropical diseases. All the cases were treated successfully and discharged in stable condition.Entities:
Keywords: dengue; leptospirosis; malaria; pregnancy; tropical diseases
Year: 2022 PMID: 35340480 PMCID: PMC8928236 DOI: 10.7759/cureus.22223
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1(A) Yellowish discoloration of the sclera. (B) Petechial hemorrhages over the supra-umbilical area. (C) Large petechial patch over the lower abdomen and bilateral thighs. (D) Petechial patch over the lateral aspect of the thigh.
Investigations of the first case
RT-PCR, reverse transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
| Laboratory parameter | Day 1 | Day 2 | Day 5 | Day 7 | Day 10 |
| Hemoglobin | 11.1 gm/dL | 10.9 gm/dL | 10.7 gm/dL | 10.5 gm/dL | 10.7 gm/dL |
| Platelet count | 17,000/dL | 68,000/dL | 75,000/dL | 110,000/dL | 135,000/dL |
| White blood cell count | 1,500/dL | 23,00/dL | 2,700/dL | 3,200/dL | 4,400/dL |
| Hematocrit | 43 | 39 | 38 | 37 | 37 |
| International normalized ratio | 2.11 | 1.42 | 1.32 | 1.31 | 1.32 |
| Urine routine microscopy | Positive for red blood cell | ||||
| Serum glutamic-oxaloacetic transaminase | 4,600 | 2,100 | 1,670 | 590 | 110 |
| Serum glutamic pyruvic transaminase | 4,300 | 2,200 | 1,580 | 555 | 105 |
| Total bilirubin | 27.1 | 20.3 | 15.1 | 9.7 | 3.2 |
| Unconjugated bilirubin | 1.8 | 1.9 | 2.4 | 0.8 | |
| Conjugated bilirubin | 25.3 | 18.4 | 13.2 | 7.3 | 2.4 |
| Non-structural antigen for dengue | Positive | ||||
| RT-PCR For SARS-CoV-2 | Negative |
Figure 2Yellowish discoloration of the sclera of case 2
Laboratory investigations of case 2
RT-PCR, reverse transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
| Laboratory parameter | Day 1 | Day 2 | Day 6 |
| Hemoglobin | 6.8 gm/dl | 7.9 gm/dL (after two units of packed red cell transfusion) | 9.6 gm/dL |
| Platelet count | 1,6000/cu mm | 59,000/cu mm (after five units of random donor platelet transfusion) | 98,000/cu mm |
| White blood cell count | 1,500/dL | 2,300/dL | 2,700/dL |
| Hematocrit | 43 | 39 | 38 |
| International normalized ratio | 2.11 | 1.42 | 1.32 |
| Urine routine microscopy | Negative for red blood cell | ||
| Serum glutamic-oxaloacetic transaminase | 3,500 | 2,320 | 110 |
| Serum glutamic pyruvic transaminase | 2,560 | 1,129 | 105 |
| Total bilirubin | 7.1 | 5.2 | 1.3 |
| Unconjugated bilirubin | 0.5 | 0.4 | 0.3 |
| Conjugated bilirubin | 5.6 | 4.8 | 1 |
| Peripheral smear for malaria | Positive | ||
| RT-PCR for SARS–CoV-2 | Negative |
Figure 3Yellowish discoloration of the sclera of case 3
Laboratory investigations of case 3
IgM, immunoglobulin M
| Laboratory parameter | Day 1 | Day 2 | Day 3 | Day 7 | Day 17 |
| Hemoglobin | 6.9 gm/dL | 8.5. gm/dL | 8.7 gm/dL | 9.2 gm/dL | 9.7 gm/dL |
| Platelet count | 15,000/dL | 40,000/dL | 56,000/dL | 99,000/dL | 117,000/dL |
| White blood cell count | 16,500/dL | 17,600/dL | 15,300/dL | 9,800/dL | 7,600/dL |
| International normalized ratio | 2.5 | 1.98 | 1.5 | 1.43 | 1.33 |
| Urine routine microscopy | Positive for red blood cell | ||||
| Serum glutamic-oxaloacetic transaminase | 2,700 | 2,200 | 1,320 | 320 | 76 |
| Serum glutamic pyruvic transaminase | 2,400 | 2,150 | 1,280 | 355 | 68 |
| Total bilirubin | 21.3 | 20.3 | 17.1 | 13.7 | 2.5 |
| Unconjugated bilirubin | 1.8 | 2.4 | 0.9 | 0.9 | 0.3 |
| Conjugated bilirubin | 19.5 | 17.9 | 16.2 | 12.6 | 2.2 |
| IgM for leptospirosis | Positive |